Uric acid test: what the number means and when gout is actually diagnosed

Short answer

A uric acid test measures urate in your blood, and on its own it cannot diagnose or rule out gout. Levels are often normal during an attack and high in millions of people who never get one. Gout is confirmed when urate crystals are found in joint fluid (2, 6).

That is the whole paradox of this test, and it trips up patients and clinicians alike. European rheumatology's 2018 recommendations say outright that "a diagnosis of gout should not be based on the presence of hyperuricaemia alone" (2). The test still earns its place — it just answers a different question than most people think they are asking.

If you were handed a normal result while your toe was still unbearable and came away feeling dismissed, you're not imagining it and it isn't your fault. The number genuinely does drop in many people during a flare (6), and a result that lands inside the reference range says very little either way. Your clinician — a primary care doctor or a rheumatologist — is the one who puts the pieces together.

Note: this article explains what guidelines and research say about testing and is not medical advice or a treatment guide. A single hot, red, acutely painful joint can be gout, but it can also be septic arthritis — a joint infection, and a medical emergency. If a hot, swollen joint comes with fever, chills, feeling generally unwell, or you can barely move the joint, seek same-day care instead of assuming it is gout; in one case series of joint infection alongside crystals, 36% of patients needed surgical drainage and 8% died (11). Call 911 for a fever with confusion, a racing heart, cold clammy skin or severe breathlessness. Only a clinician can diagnose gout.

What a uric acid test actually measures

Uric acid — urate, in clinical shorthand — is the end product your body makes when it breaks down purines, which come both from your own cells turning over and from food. Most of it leaves through the kidneys, the rest through the gut. A uric acid blood test is an ordinary draw from a vein in your arm. There is also a urine version: a 24-hour collection that measures how much urate you are clearing, used mainly to work out whether high urate is driving kidney stones (5).

The US National Library of Medicine's MedlinePlus says there is "no known risk to having a uric acid blood or urine test," does not list fasting as a requirement, and notes that medicines including aspirin and niacin (vitamin B-3) can shift the result — so tell whoever orders it what you take, and do not stop anything on your own (5).

There is one number in this whole topic that is not a statistical convention but a physical fact: at roughly 6.8 mg/dL (about 0.40 mmol/L), blood is saturated with urate. Above that, urate can come out of solution and form monosodium urate (MSU) crystals in and around joints. The American College of Rheumatology's 2020 gout guideline uses exactly that figure to define asymptomatic hyperuricemia — a serum urate of 6.8 mg/dL or more in someone who has never had a gout flare or a tophus (3).

So the test has two jobs, and they are not equally good.

Job one, as a clue when gout is suspected. MedlinePlus puts it carefully: a uric acid blood test can help diagnose gout, "usually along with a synovial fluid analysis" (5). It is one input. It is not the answer.

Job two, as a dial once gout is confirmed. Here the test is genuinely strong. ACR 2020 strongly recommends a treat-to-target strategy in which the urate-lowering drug dose is titrated using serial serum urate measurements, aiming for a serum urate below 6 mg/dL (3). Same blood test, completely different purpose: not "do I have this?" but "is the treatment working?"

Most of the confusion in this topic comes from a test that is excellent at job two being asked to do job one.

Normal uric acid levels: what the reference range is and isn't

A lab's reference range is a description of where most results in a reference population fall. It is not a line between health and disease, and MedlinePlus does not publish numeric ranges at all — it sends you to your own lab's range, because methods and populations differ between labs (5).

For scale, the most recent national US figures: in NHANES 2015–2016, mean serum urate was 6.0 mg/dL in men and 4.8 mg/dL in women. That survey defined hyperuricemia as above 7.0 mg/dL in men and above 5.7 mg/dL in women, and on that definition 20.2% of men and 20.0% of women qualified (7).

Two things follow. First, the cutoffs differ by sex — average urate is more than a milligram per decilitre lower in women than in men, and gout is correspondingly less common in women (2.7% versus 5.2%) (7). Second, the units differ by country: to convert mg/dL to mmol/L, divide by about 16.8. The 2015 classification criteria list both (6 mg/dL = 0.36 mmol/L, 10 mg/dL = 0.60 mmol/L) (1).

Here is every "normal uric acid level" you are likely to meet, and what each one is actually for.

Notice what this table does to the word "normal." A man with a urate of 6.9 mg/dL may well get an unflagged result, while sitting just above the physical point at which crystals can form. And someone already diagnosed with gout who is at 6.4 mg/dL is comfortably "in range" and still above their treatment target. "Normal" is a statement about a population; 6.8 is a statement about chemistry.

So why can my uric acid be normal during a gout attack?

Because urate often falls when a flare starts, and because the test was never a crystal detector in the first place.

The cleanest evidence comes from people enrolled in two randomized trials while they were having an acute gout attack — 339 of them, mostly men, average age 50. At the baseline draw, in the middle of a documented attack, 14% had a serum urate of 6 mg/dL or less, and 32% had 8 mg/dL or less (6). Roughly one person in seven, measured during a real attack, had a number most labs would not flag at all.

Two things are going on. Urate levels move around from day to day anyway, and the inflammatory response during a flare tends to push them down rather than up. And more fundamentally, the crystals that cause the pain were deposited over months or years; what your blood holds today is a snapshot of a process, not a measure of what is already sitting in the joint. In the same study, people already taking allopurinol had a mean urate of 7.1 mg/dL during their attack, against 8.5 mg/dL in those who were not — treatment moves the number without ending the attack (6).

The people who wrote the 2015 classification criteria built this into the rules. Their instruction for scoring serum urate: measure it ideally when the person is not taking urate-lowering treatment and more than four weeks from the start of an episode — during the symptom-free intercritical period — and retest under those conditions if practicable. The highest value ever recorded is the one that counts (1).

Read that again next time a result from the emergency room at 3 a.m. gets treated as the final word. By the criteria's own standard, that is close to the least informative moment to draw it.

There is a symmetry here that is easy to miss. A normal urate during a flare does not just fail to confirm gout — it barely counts against it either. In the scoring system, a result of 4 to below 6 mg/dL scores zero: neither for nor against. Only a result below 4 mg/dL subtracts points (1). If the picture otherwise looks like gout — and the classic picture is covered in our piece on gout symptoms — a mid-range urate is not a reason to drop the idea.

If my uric acid is high, do I have gout?

Usually not. This is the other half of the paradox, and the numbers are blunt.

In the US, about one adult in five has hyperuricemia — 20.2% of men and 20.0% of women in NHANES 2015–2016. Over the same period, the prevalence of diagnosed gout was 3.9% of adults, or 9.2 million people: 5.2% of men and 2.7% of women (7). Even allowing for undiagnosed cases, most people carrying a high number do not have gout.

The best long-running look at what happens to those people is the Normative Aging Study: 2,046 initially healthy men followed for close to 15 years, 30,147 person-years of observation. The annual rate of a first attack of gouty arthritis was 4.9% among men with a urate of 9 mg/dL or more, 0.5% at 7.0–8.9 mg/dL, and 0.1% below 7.0 mg/dL. Even in the highest group, the cumulative incidence after five years was 22% (890441-4)).

Turn that around. A man sitting at 7.5 mg/dL had, in that cohort, roughly a 99.5% chance of getting through any given year without a gout attack. High urate is a risk factor with a long fuse, not a diagnosis in waiting.

High uric acid without gout even has a formal name — asymptomatic hyperuricemia — and a formal answer. ACR 2020 conditionally recommends against starting any urate-lowering drug (allopurinol, febuxostat or probenecid) for asymptomatic hyperuricemia, defined as urate at or above 6.8 mg/dL with no prior flares and no subcutaneous tophi. Strikingly, the guideline keeps people in that category even if advanced imaging has already found urate deposits, so long as they have never had a flare or a tophus (3).

The arithmetic behind that recommendation is worth knowing, because it explains a conversation many people have with their doctor. Pooling the trial data, 24 people would need to take a urate-lowering drug for three years to prevent one gout flare (3). That is the trade a clinician is weighing when they decline to medicate a number.

None of this means a high result is meaningless. Raised urate travels with kidney stones, chronic kidney disease, high blood pressure and metabolic conditions, and MedlinePlus lists kidney disease, certain cancers, chemotherapy, alcohol use disorder and preeclampsia among the things that can push it up (5). It is a prompt to look at the rest of your health. It is not, by itself, gout.

How is gout actually diagnosed, then?

By finding monosodium urate crystals in fluid taken from the joint itself — or from a tophus — and identifying them under a polarizing microscope. Everything else is supporting evidence.

What the procedure is. Joint fluid aspiration (arthrocentesis) takes a few minutes in a clinic room. The skin is cleaned and usually numbed, a needle goes into the swollen joint or bursa, and fluid is drawn off. Draining a tense joint often relieves pressure on the spot. The fluid is then sent for three separate things: crystal analysis under polarized light, a cell count, and a Gram stain and culture to check for infection. That last one is not optional, and the reason is further down this page.

What the examiner is looking for. Under a polarizing microscope with a red compensator, MSU crystals are needle-shaped and negatively birefringent — bright yellow when the crystal lies parallel to the compensator axis, blue when perpendicular. The crystals of calcium pyrophosphate deposition disease, the condition commonly called pseudogout, are blunter and rhomboid, and show the opposite colour pattern. The 2015 criteria specify that the reading has to be done by a trained observer, because this is a skill, not a dipstick (1).

Why it settles the question. EULAR's 2018 recommendations are direct: a search for crystals in synovial fluid or tophus aspirates is recommended in every person with suspected gout, "because demonstration of monosodium urate (MSU) crystals allows a definite diagnosis of gout" (2). The US National Institute of Arthritis and Musculoskeletal and Skin Diseases describes the same step in plain language: a provider may take a sample of fluid from a painful joint, a swollen bursa or a tophus and examine it under a special microscope for urate crystals (4).

The structured version. When researchers need a reproducible definition — to decide who goes into a trial, for instance — they use the 2015 ACR/EULAR gout classification criteria, which were themselves built using crystals in synovial fluid or a tophus as the gold standard (1).

A score of 8 or more out of a maximum 23 classifies someone as having gout. Against crystal-proven cases, the full criteria had a sensitivity of 92% and a specificity of 89%; the clinical-only version, with no lab and no imaging, dropped to 85% and 78% (1).

Two things in that table deserve a second look. Serum urate is worth at most 4 points out of 23 — less than a tophus, less than an ultrasound finding, less than a single X-ray erosion. And the criteria are the only place in rheumatology where a negative joint fluid result actively subtracts points, which tells you how much weight the field puts on actually looking.

One honest caveat, from the authors themselves: these are classification criteria, designed to assemble comparable groups for research, and they write that "in clinical practice, joint or tophus aspiration remains an essential component of establishing a diagnosis of gout" (1). Clinicians borrow the criteria as a structured checklist. They were not built to replace the needle.

When aspiration doesn't happen. Sometimes the joint is too small to tap, there is no fluid to get, no trained examiner is available, or the person declines. EULAR's fallback is a list of features that support a clinical diagnosis: a single affected foot or ankle joint, especially the big-toe joint; previous episodes of similar acute arthritis; rapid onset of severe pain and swelling; redness; male sex; and associated cardiovascular disease and hyperuricaemia. Anything atypical should be imaged (2).

When do they order an ultrasound or a dual-energy CT?

Mainly when crystals cannot be obtained, or when the presentation is odd enough that the clinical picture alone is not convincing.

Ultrasound and the double contour sign. Healthy joint cartilage shows one bright line on ultrasound. When urate crystals coat the cartilage surface, a second bright, irregular line appears on top of it — the double contour sign. The 2015 criteria add a quality check: a genuine double contour sign stays put when the angle of the ultrasound beam changes, while a false one disappears (1). In the meta-analysis that informed those criteria, the pooled sensitivity of the double contour sign was 0.83 (95% CI 0.72–0.91) and specificity 0.76 (0.68–0.83). An ultrasound tophus did worse: sensitivity 0.65, specificity 0.80 (9).

Dual-energy CT (DECT). This scans at two X-ray energies and uses the difference in how materials absorb them to colour-code urate deposits separately from calcium. Pooled performance in the same meta-analysis: sensitivity 0.87 (0.79–0.93), specificity 0.84 (0.75–0.90) (9). A single-centre accuracy study found sensitivity 0.90 and specificity 0.83 — and, importantly, every false negative occurred in people with acute, recent-onset gout, while every false positive was in someone with advanced knee osteoarthritis (10).

That is the caveat that matters most if you are reading this after a first attack. The studies pooled in the imaging review were almost all done in secondary care in people whose gout had lasted at least seven years on average (9). Imaging finds deposits that have had time to accumulate. A clean ultrasound or DECT early in the disease does not rule gout out.

Plain X-ray has the same problem, more so. The gout-related erosion that scores 4 points in the criteria is a late finding; X-rays taken during a first or second attack are usually normal, which is why an unremarkable X-ray is not reassurance (1).

EULAR's position is to reach for ultrasound first when crystal identification is not possible and the presentation is atypical (2).

What else makes one joint suddenly hot and swollen

A uric acid result cannot sort these apart. That is the practical case for aspirating.

Septic arthritis — a joint infection, and an emergency. It can look almost identical to gout: one joint, hot, red, exquisitely painful. Fever, chills, feeling unwell, or being unable to move the joint at all push the odds towards infection, and it needs same-day assessment, not a wait-and-see.

Crucially, having crystals does not protect you from infection, and the two can arrive together. In a series of 25 patients with simultaneous septic and crystal-induced arthritis (mean age 67, the knee most often affected), MSU was the most common crystal found; Staphylococcus aureus was the most frequent organism, methicillin-sensitive in 48% and methicillin-resistant in 12%, with tuberculosis in another 12%. Thirty-six per cent needed surgical drainage and 8% died (11). This is precisely why joint fluid goes for Gram stain and culture as well as crystal analysis: finding urate crystals does not mean the joint is not also infected.

Calcium pyrophosphate deposition (pseudogout). Different crystal, different microscope result — rhomboid and positively birefringent — and a preference for knees and wrists in older adults.

Cellulitis, a skin and soft-tissue infection, can mimic a red swollen joint from the outside while the joint itself moves normally.

Other inflammatory arthritis. Rheumatoid arthritis usually announces itself differently, with symmetrical small-joint involvement and morning stiffness, and has its own diagnostic pathway — see how rheumatoid arthritis is diagnosed and the four stages of rheumatoid arthritis. Psoriatic arthritis can produce a swollen toe that genuinely looks gouty. Reactive arthritis follows an infection elsewhere, often in the gut or urinary tract, by a week or two.

Osteoarthritis flares are usually slower and less dramatic, though a sudden inflamed knee can confuse things; the differences are laid out in osteoarthritis vs rheumatoid arthritis.

Treatment of gout, once it is confirmed, is a separate subject and a separate conversation with your clinician — this page is about getting the diagnosis right, not about what to take.

Living with a uric acid result: the questions people ask next

Do I need to fast before a uric acid test?

MedlinePlus does not list fasting as a requirement for a uric acid blood test, and describes it as an ordinary draw from a vein with no known risk (5). Some labs and some ordering clinicians still ask for a fast, usually because the urate is being drawn alongside glucose or a lipid panel. Follow the instruction on your own requisition, and tell whoever orders it about aspirin, niacin and any other medicines, since those can move the result (5).

My level is 7.5 mg/dL and I've never had an attack. What happens now?

In most cases, nothing in the way of medication. That is asymptomatic hyperuricemia, and ACR 2020 conditionally recommends against starting a urate-lowering drug for it, with the number-needed-to-treat arithmetic behind that decision being 24 people for three years to prevent a single flare (3). In the Normative Aging Study, men in the 7.0–8.9 mg/dL band had a 0.5% annual rate of a first gout attack (890441-4)). What usually does happen is a look at the company that high urate keeps — blood pressure, kidney function, weight, alcohol, and the medicines you take. That is your clinician's call, not a self-management project.

Does joint fluid aspiration hurt?

It is a needle into an already painful joint, so expect discomfort, but the skin is normally numbed first and the procedure takes minutes. Many people find a tense, swollen joint feels better afterwards because the pressure is relieved. NIAMS lists it as a routine part of working out whether a painful joint is gout (4). The fluid also answers a question nothing else can: whether the joint is infected.

My attack is over and my doctor wants to retest my uric acid. Why?

Because that is the measurement the guidelines actually want. The 2015 criteria specify scoring serum urate when someone is off urate-lowering treatment and more than four weeks from the start of an episode, retesting under those conditions where practicable (1). A level drawn mid-flare, especially on treatment, is the least representative one you will ever have (6).

Can a home uric acid meter replace the lab test?

No, and more importantly it would not answer the question you want answered. Even a perfectly accurate home urate number cannot diagnose gout, cannot rule it out, and cannot distinguish a flare from a joint infection. Where home or point-of-care measurement is sometimes discussed is in monitoring treatment once gout is confirmed and a target is set — and that is a decision for the clinician managing your treat-to-target plan (3).

I already have gout. Why does my doctor keep ordering this test?

This is job two, and here the test is at its best. ACR 2020 strongly recommends titrating urate-lowering therapy against serial serum urate measurements with a target below 6 mg/dL (3). Under-treatment is the norm rather than the exception: in NHANES data, only about a third of people with gout were receiving urate-lowering therapy at all (7).

What if nobody ever took fluid from my joint?

You are in a large group. Gout is often diagnosed on the clinical picture alone, and EULAR explicitly provides for that, listing the supporting features and recommending imaging for anything atypical (2). But if attacks keep coming, if the diagnosis has never been confirmed, if treatment is not working, or if a new joint behaves differently from the others, asking for aspiration during an active flare is a reasonable request — and the one test that can settle it.

How to bring this up with your doctor

First, the things that are not a conversation to schedule. A hot, swollen, severely painful joint together with fever, chills, feeling generally unwell, or an inability to move the joint needs same-day medical care — septic arthritis is a medical emergency, it can coexist with crystals, and in one series of joint infection alongside crystal arthritis 36% of patients needed surgical drainage and 8% died (11). Call 911 for fever with confusion, a racing heart, cold clammy skin, severe breathlessness, or spreading redness with streaking up a limb. Sudden chest pain, one-sided weakness or trouble speaking are 911 regardless of what your joint is doing.

What to bring. The dates of every episode you can reconstruct, which joint each one hit, how fast the pain peaked, how long it lasted, and whether the joint returned completely to normal in between. Those three time-course items — peak under 24 hours, settling within 14 days, full resolution between attacks — are literally scored in the classification criteria, and most people can answer them better from notes than from memory (1). Bring your medication list too, including diuretics, low-dose aspirin and niacin (5).

What to say. "I've had three episodes like this. The worst pain comes on overnight and peaks within a day, it's always the same joint, and it clears completely in about a week. I'd like to know whether this is gout and how we can confirm it."

What to ask for.

• "While this joint is still swollen, can we aspirate it and look for crystals?" This is the one window when the decisive test is easy, and EULAR recommends looking in every person with suspected gout (2).

• "Is the fluid going for Gram stain and culture as well as crystals?" Finding urate does not exclude infection (11).

• "Can we repeat my uric acid in a few weeks, once this has settled and off any treatment?" (1)

• "If we can't get fluid, would an ultrasound of the joint be useful?" (2, 9)

If a normal result is used to close the subject. It is fair to say, calmly: "I understand the urate came back normal. My understanding is that about one in seven people measured during an actual gout attack have a level of 6 or below, and that the classification criteria score a result between 4 and 6 as neither for nor against. Does that change what we do next?" You are not arguing with your doctor; you are asking for the next step, which is usually either aspiration, imaging, or a repeat urate a month after the flare. If the diagnosis stays uncertain and attacks keep happening, asking for a referral to a rheumatologist is a normal request, not an escalation.

Start understanding your body

Learn what affects your energy, stress, sleep, and daily state. Get the app.

Explore your data

How Welltory helps — and what it cannot do

The limits, first, because they are the important part here. Welltory is a general wellness product, not a medical device. It does not diagnose, detect, predict, monitor, prevent, treat or mitigate any condition. It cannot identify gout, it cannot tell a flare from a joint infection, and it does not measure uric acid — there is no consumer wearable that does. Nothing in the app is a substitute for the blood draw or the needle described above. Per Welltory's help centre, measurements may also be inaccurate for people under 18 and during pregnancy (12).

What it can do is hold a dated record of your own days. Gout arrives in episodes, and the appointment that follows is a memory test: when did it start, which joint, how fast did the pain peak, how long did it last, what did you eat and drink the day before, had you been ill or dehydrated. Those are exactly the questions the 2015 criteria turn into points (1), and a dated log answers them better than recall does weeks later.

You note the event; the app records the background. Add a tag from the plus sign at the top of the feed — "left big toe, woke at 3am", "two beers", "walked 18k steps". When the Today screen flags a stress or rest stretch it asks "What happened?"; you can tap a suggested tag, type, or talk, and correct the tags before saving.

The same measurement, every day, taken the same way. Resting heart rate, heart rate variability, stress minutes, Battery and sleep are recorded identically day to day, so the comparison is always with your own recent baseline rather than with a population line. Battery and stress minutes need iOS with an Apple Watch or Oura. None of these numbers is a gout signal. They are context: what your sleep and resting heart rate were doing around the days you flagged.

Over a few months, My Patterns looks for what your tags have in common (iOS with an Apple Watch or Oura). Patterns start to appear at around seven tagged events in a month, so a couple of flares will not generate one — this is a tool for the slow background of alcohol, sleep debt, travel and dehydration, not for the attack itself. Anything it surfaces is an association to discuss with your doctor, not a cause.

A record you can hand over. The Journal (Premium) keeps measurements, tags and notes together, and from the web app you can export a CSV: Dashboard → choose a chart → Export. A page of dated entries — "Mar 3, right big toe, peak pain by morning, resolved Mar 9" — is more useful in a ten-minute appointment than trying to remember.

Why there is no chart of our own user data on this page. We did not publish one, and the reason is the subject of the article. Welltory does not measure urate and has no crystal-confirmed gout cohort; the only thing we could plot is heart rate or HRV around self-reported "gout" tags, which would be confounded by pain, poor sleep, alcohol and any medication taken — and it would look like evidence while being none. Given that this page exists to explain why one number is not a diagnosis, adding a second misleading number would be a poor trade.

The same red flags apply here, in the same type size: a hot, swollen joint with fever, chills, feeling unwell or an inability to move it needs same-day care, whatever your data shows — septic arthritis is an emergency (11).

How we made it

Made with AI tools, then edited and fact-checked by the Welltory team. See our Editorial & AI policy.

Jane Smorodnikova, co-founder of Welltory, built the methodology behind how we read physiological data.

Written by Tatsiana Yashyna.

Discounts for blog readers: up to 36% off

See what affects your energy, stress, sleep, and daily state with Welltory

Explore your data